Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
42 studies found for:    Open Studies | "Kidney Diseases, Cystic"
Show Display Options
Rank Status Study
21 Recruiting The Eurocyst Initiative: Building a Network of ADPKD Reference Centers Across Europe
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention:
22 Recruiting Clinical Care of Autosomal Polycystic Kidney Disease: Retrospective Analysis and Prospective PKD Genotyping
Condition: ADPKD
Intervention:
23 Recruiting Randomized Trial of NSAID vs Placebo Prior to Ureteral Stent Removal
Conditions: Disorder of Urinary Stent;   Ureteral Spasm;   Ureteropelvic Junction Obstruction;   Urolithiasis
Interventions: Drug: Ibuprofen;   Drug: Placebo
24 Recruiting The Efficacy of Everolimus in Reducing Total Native Kidney Volume in Polycystic Kidney Disease Transplanted Recipients
Condition: Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: Everolimus;   Drug: Calcineurin inhibitors maintenance
25 Recruiting Lanreotide In Polycystic Kidney Disease Study
Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD
Interventions: Drug: Lanreotide;   Drug: saline
26 Unknown  Triptolide-Containing Formulation as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Interventions: Drug: Triptolide-Containing Formulation;   Drug: Placebo
27 Recruiting Clinical and Molecular Description of PKD1 and PKD2 Mutation Negative Carriers in ADPKD
Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Intervention: Other: Blood Collection
28 Unknown  Renal Sympathetic Denervation for Reduction of Pain and Improvement of Insulin Sensitivity in Adult Polycystic Kidney Disease
Condition: Adult Polycystic Kidney Disease
Intervention: Procedure: renal denervation
29 Recruiting Pulsed Oral Sirolimus in Autosomal Dominant Polycystic Kidney Disease
Conditions: Polycystic Kidney, Type 1 Autosomal Dominant Disease;   Polycystic Kidney, Type 2 Autosomal Dominant Disease
Interventions: Drug: Sirolimus;   Drug: Placebo
30 Unknown  Radiofrequency Ablation for ADPKD Blood Pressure and Disease Progression Control
Conditions: Autosomal Dominant Polycystic Kidney Disease;   Hypertension
Interventions: Procedure: renal sympathetic denervation;   Drug: antihypertensive drugs
31 Recruiting PKD Clinical and Translational Core Study
Condition: Polycystic Kidney Disease
Intervention:
32 Unknown  The Correlation Between Renal Injury and Biomarkers in Pediatric Ureteropelvic Junction Obstruction Patients
Condition: Ureteropelvic Junction Obstruction
Intervention:
33 Unknown  Sirolimus for Massive Polycystic Liver
Condition: Polycystic Kidney Diseases
Intervention: Drug: Sirolimus
34 Recruiting A Safety, Pharmacokinetic and Dose-Escalation Study of KD019 in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Condition: Polycystic Kidney, Autosomal Dominant
Intervention: Drug: KD019 (tesevatinib)
35 Unknown  Efficacy and Safety Study of Second-Line Treatment for Hypertension With Autosomal Dominant Polycystic Kidney Disease(ADPKD)
Condition: Kidney, Polycystic, Autosomal Dominant
Interventions: Drug: Cilnidipine;   Drug: Imidapril
36 Recruiting Polycystic Kidney Disease Data Repository
Condition: Polycystic Kidney Disease
Intervention:
37 Unknown  Ambulatory Blood Pressure Measurement in Children With Congenital Urine Flow Obstruction
Conditions: Hydronephrosis;   Multicystic-Dysplastic Kidney
Intervention: Device: 24-hour ambulatory blood pressure monitor
38 Recruiting Autosomal Dominant Polycystic Kidney Disease (ADPKD) Pain Study
Condition: Kidney, Polycystic, Autosomal Dominant
Intervention: Procedure: video thorascopic splanchnicectomy (VSPL)
39 Unknown  CCB Safety Study in Treatment of Hypertension of ADPKD
Condition: Kidney, Polycystic, Autosomal Dominant
Interventions: Drug: Candesartan;   Drug: Candesartan and Cilnidipine;   Drug: Candesartan plus non-CCB agents
40 Unknown  Ureteropelvic Junction Obstruction in Early Childhood: Comparison of Surgical Therapy and Surveillance. A Prospective, Randomized, Controlled Multi-Center Study
Condition: Unilateral Ureteropelvic Junction Obstruction
Intervention: Procedure: Pyeloplasty

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-42) Show next page of results    Last Page
Indicates status has not been verified in more than two years